Kepos Capital’s Exact Sciences EXAS Stock Holding History

Kepos Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,176	Closed	-$849K	–	213
2019 Q4	$849K	Sell	9,176 -1,832	-17%	-$161K	0.08%	158
2019 Q3	$995K	Buy	+11,008	New	+$1.25M	0.1%	121

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kepos Capital's EXAS Position: Q1 2020 in Review

Kepos Capital sold out of Exact Sciences (EXAS) in Q1 2020, closing a stake of 9,176 shares — an estimated $849K sold.

Kepos Capital first reported a position in EXAS in Q3 2019 and held it in 2 quarters. The position peaked at $995K in Q3 2019. 476 funds tracked by Wall St. Rank hold EXAS as of Q1 2020.

Kepos Capital reported no remaining Exact Sciences position as of Q1 2020 after selling out during the quarter.
Kepos Capital sold 9,176 Exact Sciences shares in Q1 2020, an estimated $849K.
Kepos Capital first reported a position in Exact Sciences in Q3 2019 and held it in 2 quarters.
Kepos Capital's Exact Sciences position peaked at $995K in Q3 2019.
476 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2020.

Based on Kepos Capital's 13F filing for Q1 2020, filed 12 May 2020.